Full text is available at the source.
Abstract
Effects of liraglutide on metabolic control and satiety were evaluated in patients with congenital generalized lipodystrophy (CGL).
- Evidence on the use of glucagon-like peptide 1 receptor agonists (GLP-1RAs) in lipodystrophies is limited.
- The study focused on patients with congenital generalized lipodystrophy (CGL).
- Liraglutide may influence metabolic control and satiety in this patient population.
Simplified